Heriot REIT Limited (JSE:HET)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 15.00
0.00 (0.00%)
At close: Jul 29, 2025, 5:00 PM SAST
Marinus Pharmaceuticals Balance Sheet
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2020 |
Property, Plant & Equipment | 11,924 | 11,495 | 9,018 | 5,111 | 4,668 | 4,533 | Upgrade |
Cash & Equivalents | 145.13 | 69.03 | 45.7 | 122.96 | 110.3 | 86.26 | Upgrade |
Accounts Receivable | 102.45 | 37.35 | 20.18 | 5.72 | 5 | 8.8 | Upgrade |
Other Receivables | 0.83 | 21.21 | 10.6 | 25.69 | 18.34 | 9.8 | Upgrade |
Investment In Debt and Equity Securities | - | 212.87 | 1.02 | - | 38.48 | - | Upgrade |
Loans Receivable Current | - | - | - | 49.57 | 50.31 | 45.62 | Upgrade |
Other Current Assets | 496.87 | 237.52 | 321.54 | 13.88 | 18.16 | 61.65 | Upgrade |
Trading Asset Securities | - | 0.16 | 1.62 | - | - | - | Upgrade |
Other Long-Term Assets | 311.09 | 101.09 | 78.56 | 367.67 | 39.87 | 42.45 | Upgrade |
Total Assets | 12,981 | 12,174 | 9,498 | 5,697 | 4,948 | 4,787 | Upgrade |
Current Portion of Long-Term Debt | 277.78 | 164.93 | 649.24 | 247.06 | 436.93 | 132.19 | Upgrade |
Current Portion of Leases | 0.9 | 0.82 | 0.99 | - | - | - | Upgrade |
Long-Term Debt | 5,060 | 4,888 | 3,225 | 1,969 | 1,397 | 1,652 | Upgrade |
Long-Term Leases | 1.67 | 2.15 | 4.53 | - | - | - | Upgrade |
Accounts Payable | 212.06 | 6.41 | 1.24 | 1.63 | 3.63 | 2.18 | Upgrade |
Accrued Expenses | - | 115.8 | 93.87 | 63.01 | 50 | 38.52 | Upgrade |
Current Income Taxes Payable | - | 0.07 | 0.4 | - | 0.03 | - | Upgrade |
Current Unearned Revenue | - | 24.34 | 33.03 | 11.85 | 13.5 | 12.48 | Upgrade |
Other Current Liabilities | 12.22 | 86.22 | 108.31 | 20.69 | 18.49 | 13.85 | Upgrade |
Long-Term Deferred Tax Liabilities | 113.51 | 104.07 | 76.29 | 62.09 | 63.73 | 63.42 | Upgrade |
Total Liabilities | 5,678 | 5,393 | 4,193 | 2,375 | 1,984 | 1,914 | Upgrade |
Common Stock | 3,469 | 3,478 | 2,558 | 2,558 | 2,558 | 2,558 | Upgrade |
Retained Earnings | 2,653 | - | - | - | - | - | Upgrade |
Treasury Stock | - | -9 | -9 | -9 | -9 | -9 | Upgrade |
Comprehensive Income & Other | - | 2,205 | 1,405 | 730.47 | 369.39 | 279.3 | Upgrade |
Total Common Equity | 6,122 | 5,673 | 3,954 | 3,279 | 2,918 | 2,828 | Upgrade |
Minority Interest | 1,181 | 1,107 | 1,351 | 42.39 | 46.55 | 45.14 | Upgrade |
Shareholders' Equity | 7,303 | 6,781 | 5,304 | 3,321 | 2,965 | 2,873 | Upgrade |
Total Liabilities & Equity | 12,981 | 12,174 | 9,498 | 5,697 | 4,948 | 4,787 | Upgrade |
Total Debt | 5,340 | 5,056 | 3,880 | 2,216 | 1,834 | 1,784 | Upgrade |
Net Cash (Debt) | -5,195 | -4,987 | -3,833 | -2,093 | -1,724 | -1,698 | Upgrade |
Net Cash Per Share | -18.06 | -19.50 | -15.01 | -8.19 | -6.75 | -6.65 | Upgrade |
Filing Date Shares Outstanding | 319.26 | 319.26 | 255.4 | 255.4 | 255.4 | 255.4 | Upgrade |
Total Common Shares Outstanding | 319.26 | 319.26 | 255.4 | 255.4 | 255.4 | 255.4 | Upgrade |
Book Value Per Share | 19.17 | 17.77 | 15.48 | 12.84 | 11.43 | 11.07 | Upgrade |
Tangible Book Value | 6,122 | 5,673 | 3,954 | 3,279 | 2,918 | 2,828 | Upgrade |
Tangible Book Value Per Share | 19.17 | 17.77 | 15.48 | 12.84 | 11.43 | 11.07 | Upgrade |
Construction In Progress | - | 92.53 | 91.35 | 129.26 | 109.24 | 89.46 | Upgrade |
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.